Scarica l'app Stockscreener
3.85
1.07%
0.10
Endra Life Sciences Inc Azioni (NDRA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.35%
1.3707
|
1.3011 | 1.4693 | 2.2309 | 2.7805 |
| Operating Income/Loss |
5.35%
-1.3707
|
-1.3011 | -1.4693 | -2.2309 | -2.7805 |
| Nonoperating Income/Loss |
-0.2253
|
- | - | 0.0017 | 0.00484 |
| Income/Loss From Continuing Operations Before Tax |
30.19%
-1.596
|
-1.2259 | -1.0363 | -2.2292 | -2.7757 |
| Income/Loss From Continuing Operations After Tax |
30.19%
-1.596
|
-1.2259 | -1.0363 | -2.2292 | -2.7757 |
|
Net Income/Loss
|
30.19%
-1.596
|
-1.2259 | -1.0363 | -2.2292 | 2.7757 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | 5.5514 |
| Basic Average Shares |
0.7612
|
- | - | - | - |
| Diluted Average Shares |
0.7612
|
- | - | - | - |
| Basic Earnings Per Share |
-2.10
|
- | - | - | - |
| Diluted Earnings Per Share |
-2.10
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.03%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):